Armistice Capital’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-236,000
Closed -$732K – 381
2026
Q2
$732K Buy
+236,000
New +$726K 0.01% 198

Other funds holding CODX

Armistice Capital's CODX Position: Q3 2026 in Review

Armistice Capital sold out of Co-Diagnostics (CODX) in Q3 2026, closing a stake of 236,000 shares — an estimated $732K sold.

Armistice Capital first reported a position in CODX in Q2 2026 and held it in 1 quarter. The position peaked at $732K in Q2 2026. 24 funds tracked by Wall St. Rank hold CODX as of Q3 2026.

  • Armistice Capital reported no remaining Co-Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Armistice Capital sold 236,000 Co-Diagnostics shares in Q3 2026, an estimated $732K.
  • Armistice Capital first reported a position in Co-Diagnostics in Q2 2026 and held it in 1 quarter.
  • Armistice Capital's Co-Diagnostics position peaked at $732K in Q2 2026.
  • 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2026.

Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.